J1740 – Injection, ibandronate sodium, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1740
- Long description
- Injection, ibandronate sodium, 1 mg
- Short description
- Ibandronate sodium injection
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2007
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code J1740?
J1740 is a HCPCS Level II code for injection, ibandronate sodium, 1 mg.
Does Medicare cover J1740?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1720 – Injection, hydrocortisone sodium succinate, up to 100 mg
- J1725 – Injection, hydroxyprogesterone caproate, 1 mg
- J1726 – Injection, hydroxyprogesterone caproate, (makena), 10 mg
- J1729 – Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
- J1730 – Injection, diazoxide, up to 300 mg
- J1736 – Injection, meloxicam (delova), 1 mg
- J1737 – Injection, meloxicam (azurity), 1 mg
- J1738 – Injection, meloxicam, 1 mg
- J1741 – Injection, ibuprofen, 100 mg
- J1742 – Injection, ibutilide fumarate, 1 mg
- J1743 – Injection, idursulfase, 1 mg
- J1744 – Injection, icatibant, 1 mg
- J1745 – Injection, infliximab, excludes biosimilar, 10 mg
- J1746 – Injection, ibalizumab-uiyk, 10 mg
- J1747 – Injection, spesolimab-sbzo, 1 mg
- J1748 – Injection, infliximab-dyyb (zymfentra), 10 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.